Brazil Health Authority to Reevaluate Ban on E-Cigarettes

Regulations by 2FIRSTS.ai
Apr.12.2024
Brazil Health Authority to Reevaluate Ban on E-Cigarettes
Brazil's health regulator ANVISA plans to reassess the ban on e-cigarettes, including pods and vapes, on April 17.

According to Brazilian media Olhar Digital, the Brazilian Health Surveillance Agency (ANVISA) plans to reassess the ban on e-cigarettes. This discussion will include e-cigarettes, pods, and vapes, and the assessment will take place on April 17th (Wednesday).

 

As early as 2009, e-cigarettes and unheated tobacco have been banned for sale in Brazil. In 2019, ANVISA revisited these products, with the report being delivered by the agency's president Antonio Barra. In December 2023, ANVISA conducted a public consultation to evaluate whether to continue the ban on these products, receiving a total of 13,390 feedback responses.

 

The department will compile a revised version of the text based on the data collected, expected to be submitted next week. However, the final decision may take longer, as more time may be needed for evaluating the new proposal and accommodating requests for postponement, with some agency members indicating that the original ban may remain in place.

 

According to last year's public consultation results, 37% of people support the e-cigarette ban, while 59% are against the ban or have reservations about sales of e-cigarettes. Among healthcare professionals, 61% agree with the ban, while 32% hold opposing views.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
Smoore's Subsidiary CCELL Faces Antitrust Lawsuit in the U.S., Accused of Price Manipulation and Market Monopoly
A U.S. federal court in Arizona has recently accepted a class-action lawsuit against Chinese e-cigarette manufacturer Smoore and its U.S. distributor. The suit accuses them of monopolizing the U.S. cannabis vape market through price manipulation and market division, resulting in higher costs for consumers. This marks the second such case filed this year.
Jul.03 by 2FIRSTS.ai
2Firsts Interview with Alchem: Addressing Quality, Speed, and Regulation in Next-Gen Nicotine Solutions
2Firsts Interview with Alchem: Addressing Quality, Speed, and Regulation in Next-Gen Nicotine Solutions
As global regulations tighten and demand for smoke-free alternatives grows, the nicotine industry is rapidly evolving. In an interview with 2Firsts, Alchem discusses how enhanced purity, consistency, and technological innovation help address quality, speed, and compliance challenges.
Jul.10
Product | First Wave of Listings After UK Ban: Nearly 200 Pod SKUs Released, with HAYATI, FUMOT Among Key Launches
Product | First Wave of Listings After UK Ban: Nearly 200 Pod SKUs Released, with HAYATI, FUMOT Among Key Launches
In the first week following the UK's disposable vape ban, the MHRA database showed zero active disposable product SKUs. Meanwhile, 194 new SKUs were added under refillable e-liquid containers and pods. Brands like RELX, FUMOT, HAYATI, and INNOKIN actively listed a wide range of 20mg/ml standard pods and pod-based devices.
Jun.05 by 2FIRSTS.ai
Asia-Pacific Tobacco Harm Reduction Advocates Criticize WHO Policy Shift, Say It Harms India and Other Low- and Middle-Income Countries
Asia-Pacific Tobacco Harm Reduction Advocates Criticize WHO Policy Shift, Say It Harms India and Other Low- and Middle-Income Countries
The Asia-Pacific Coalition on Tobacco Harm Reduction (CAPHRA) warns that WHO’s recent policy shift contradicts evidence and harms low- and middle-income countries like India, which has over 45 million livelihoods tied to tobacco. CAPHRA criticizes WHO’s double standard of banning safer alternatives in poorer countries but not in high-income ones, increasing health inequality.
Jul.23 by 2FIRSTS.ai
Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally
Reynolds Tobacco Company Wins U.S. Supreme Court Support to Challenge FDA Ruling Locally
On June 20, the U.S. Supreme Court ruled 7-2 in favor of e-cigarette companies, making it easier for them to sue over FDA decisions blocking product market entry. The case, filed by RJ Reynolds, challenges FDA’s denial of the Vuse Alto e-cigarette. The ruling could shift the balance between the industry and regulators.
Jun.23 by 2FIRSTS.ai
Montgomery County, U.S., Receives $1.3 Million from JUUL Settlement for Youth Support Programs
Montgomery County, U.S., Receives $1.3 Million from JUUL Settlement for Youth Support Programs
Montgomery County, Maryland, will use over $1.3 million from the JUUL and Altria settlement to fund youth mental health and substance abuse prevention programs, including soccer coaching and vaping cessation initiatives, with a focus on communities heavily impacted by e-cigarette use.
Jul.30 by 2FIRSTS.ai